Normal view MARC view ISBD view

Carfilzomib for relapsed or refractory multiple myeloma.

Tanimoto, Tetsuya

Carfilzomib for relapsed or refractory multiple myeloma. [electronic resource] - The Lancet. Oncology 01 2018 - e1 p. digital

Publication Type: Letter; Comment

ISSN: 1474-5488

Standard No.: 10.1016/S1470-2045(17)30859-8 doi

Subjects--Topical Terms:
Humans
Multiple Myeloma
Neoplasm Recurrence, Local
Oligopeptides
Proteasome Inhibitors

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)